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ABSTRACT
Background. Improvement in mortality has been shown
for esophagectomies performed at high-volume centers.
Objective. This study aimed to determine if centralization
of esophageal cancer surgery occurred in the US, and to
establish its impact on postoperative mortality. In addition,
we aimed to analyze the relationship between regional-
ization of cancer care and health disparities.
Methods. A retrospective population-based analysis was
performed using the National Inpatient Sample for the
period 2000–2014. Adult patients (C 18 years of age)
diagnosed with esophageal cancer and who underwent
esophagectomy were included. Yearly hospital volume was
categorized as low (\ 5 procedures), intermediate (5–20
procedures), and high ([ 20 procedures). Multivariable
analyses on the potential effect of hospital volume on
patient outcomes were performed, and the yearly rate of
esophagectomies was estimated using Poisson regression.
Results. A total of 5235 patients were included.
Esophagectomy at low- [odds ratio (OR) 2.17] and inter-
mediate-volume (OR 1.62) hospitals, compared with high-
volume hospitals, was associated with a significant increase
in mortality. The percentage of esophagectomies per-
formed at high-volume centers significantly increased
during the study period (29.2–68.5%; p\ 0.0001). The
trend towards high-volume hospitals was different among
the different US regions: South (7.7–54.3%), West
(15.0–67.6%), Midwest (37.3–67.7%), and Northeast
(55.8–86.8%) [p\ 0.0001]. Overall, the mortality rate of
esophagectomy dropped from 10.0 to 3.5% (p = 0.006),
with non-White race, public insurance, and low household
income patients also showing a significant reduction in
mortality.
Conclusions. A spontaneous centralization for esophageal
cancer surgery occurred in the US. This process was
associated with a decrease in the mortality rate, without
contributing to health disparities.
Keywords Esophageal cancer  Centralization 
Mortality  Disparities
The incidence of esophageal cancer, particularly eso-
phageal adenocarcinoma, is expected to rise dramatically
in many Western countries.1 Surgical resection is the
cornerstone of curative treatment. Although there has been
a significant improvement in operative techniques and
postoperative care, esophagectomy remains one of the most
demanding surgical procedures, with significant associated
morbidity and mortality.2,3
The relationship between hospital operative volume and
postoperative mortality rates after complex surgical pro-
cedures has been clearly established.4–7 Specifically, it has
been shown that operative volume is an important deter-
minant of quality of care for esophagectomy;8–11 thus, the
potential advantages of centralizing esophageal cancer
surgery continue to be discussed in many healthcare sys-
tems. With the lack of uniform prescriptive guidelines or
operative volume standards implementation, the attainment
of centralization of esophageal cancer surgery is currently
still aspirational in the US, which can be attributed to
several factors. First, many patients prefer to seek
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definitive cancer care near home at their local community
hospital rather than travel far to an unknown center. Sec-
ond, with variations in healthcare system networks across
the country, determining centers of excellence designation
and steering patient referrals to such centers is challenging.
Lastly, the financial implications of patient referral to high-
volume centers may be a disincentive to centralization of
care.
Scarce data are available regarding the occurrence of a
nationwide spontaneous concentration of esophageal can-
cer surgery in high-volume centers. We therefore aimed to
characterize the trend of centralization of esophageal can-
cer surgery in the US and to determine its impact on
postoperative mortality. In addition, we aimed to analyze
the relationship between regionalization of cancer care and
health disparities.
METHODS
We performed a retrospective analysis of the National
Inpatient Sample (NIS) database between 1 January 2000
and 31 December 2014. The NIS is the largest publically
available all-payer healthcare database in the US, and
includes over 7 million hospitalizations from 1000 hospi-
tals each year, representing a 20% stratified sample of all
hospital discharges in the US. Eligible patients were
identified using International Classification of Disease, 9th
Revision, Clinical Modification (ICD-9-CM) diagnostic
and procedural codes.
Adult patients (C 18 years of age) diagnosed with eso-
phageal cancer (ICD-9-CM 150–150.9) who underwent an
elective esophagectomy (42.4–42.42, 42.58, and
42.6–42.69) during their inpatient hospitalization were
eligible for inclusion. Yearly hospital volume was calcu-
lated by summing the number of patients and applying the
discharge weights included in the NIS, which weights
observations so that counts are nationally representative.
Patients with missing weights or weights of 0 were
excluded (n = 8).
Surgical outcomes of interest were inpatient mortality,
postoperative complications during the index hospitaliza-
tion, hospital length of stay, and total charges (excluding
operating room time costs). Postoperative complications
included venous thromboembolism (415.11,
453.40–453.42, and V12.51), wound complications
(998.13, 998.30–998.32, and 998.83), infection (54.91,
86.04, 567.22, 569.5, 995.9–995.99, 996.64, 998.5–998.59,
and 999.3–999.39), esophageal perforation (42.82 and
530.4), postoperative bleeding (99.0–99.09, 998.11, and
998.12), shock (998.0–998.09), cardiac failure (410–410.9,
428–428.9), renal failure (38.95, 39.95, 584–584.9, 586,
and V45.11), and respiratory failure (31.1–31.29, 96.04,
96.05, 96.7–96.72, and 799.1). A composite complication
(i.e. at least one postoperative complication) was also
analyzed.
Comorbidities of interest included hypertension
(401–401.9 and 402–402.91), primary and secondary dia-
betes (249–249.91 and 250–250.93), obesity (278–278.8),
renal insufficiency (585–585.9), coronary artery disease
(414–414.9), peripheral vascular disease (443–443.9),
chronic obstructive pulmonary disease (491–492.8), and
sleep apnea (327.23).
Statistical Analysis
Yearly hospital volume was categorized as low (\ 5
procedures), intermediate (5–20 procedures), and high
([ 20 procedures). Patient demographics, hospital charac-
teristics, and procedure type were compared across hospital
surgical volume using Chi square (V2) and analysis of
variance (ANOVA) tests, where appropriate. Unadjusted,
bivariate analyses of inpatient mortality, length of stay,
hospital charges, and complication incidence across hos-
pital surgical volume were conducted using Chi square
(V2) and Wilcoxon–Mann–Whitney tests.
Missing data for race/ethnicity (n = 1004, 19.2%), pri-
mary insurance (n = 20, 0.4%), household income
(n = 124, 2.4%), hospital teaching status (n = 9, 0.2%),
bed size (n = 9, 0.2%), inpatient mortality (n = 4, 0.1%),
and hospital charges (n = 171, 3.3%) were estimated using
Markov Chain Monte Carlo (MCMC) multiple imputation
(n = 40). A non-informative prior, 200 burn-in iterations
and 100 iterations between imputations was specified.
MCMC models included the variables with missing data
plus all postoperative complications, length of stay, admit
year, age, comorbidities, and hospital region. Variable
estimates were not rounded or bounded.
Multivariable analyses on the potential effect of hospital
volume on patient outcomes were performed on the
imputed datasets using linear and logistic regression, where
appropriate. Models were adjusted for admit year, sex, age,
race/ethnicity, comorbidities, primary insurance, household
income, hospital region, hospital size, and teaching status.
Age was modeled as a restricted cubic spline.
The yearly rate of esophagectomies, stratified by hos-
pital volume category, was estimated using Poisson
regression. The yearly rate of esophagectomies at high-
volume centers, stratified by US Census regions (Northeast,
Midwest, South, and West), was also estimated using
Poisson regression.12 Differences across regions were
assessed using a likelihood ratio test (LRT). Due to chan-
ges in NIS sampling strategy, discharge records from 2012
to 2014 were excluded in all trend analyses. Additionally,
the yearly rate of postoperative mortality, stratified by race
(non-Hispanic White vs. other race), household income
(lowest vs. medium/high/highest), and primary insurance
type (private vs. public) was assessed using Poisson
regression, and differences across groups were assessed
using LRT.
All analyses were performed using SAS software ver-
sion 9.4 (SAS Institute, Inc., Cary, NC, USA). A
p value\ 0.05 was considered significant.
RESULTS
A total of 5235 patients were included. During the study
period, 52.2% of patients underwent esophagectomy in
high-volume hospitals, 35.0% in intermediate-volume
hospitals, and 12.8% in low-volume hospitals. Non-His-
panic White race, private primary insurance, and higher
household income were more prevalent at high-volume
hospitals (p\ 0.0001). The majority (94.8%) of the high-
volume centers consisted of urban teaching hospitals
(p\ 0.0001). Patient and hospital characteristics, stratified
by hospital volume, are described in Table 1.
Compared with high-volume hospitals, low- and inter-
mediate-volume hospitals had a significantly higher
incidence of postoperative infection (16.5 and 14.4%,
respectively, vs. 12.0%; p = 0.003), bleeding (24.9 and
20.2% vs. 18.8%; p = 0.003), cardiac failure (7.6 and
6.4% vs. 5.1%; p = 0.02), renal failure (10.0 and 8.5% vs.
6.4%; p = 0.001), respiratory failure (28.3 and 24.4% vs.
18.5%; p\ 0.0001), and inpatient mortality (10.2 and
6/7% vs. 3.9%; p\ 0.0001). The median length of hospital
stay was 14 days (interquartile range [IQR] 10–20) for
low-volume hospitals, 12 days (IQR 9–19) for intermedi-
ate-volume hospitals, and 11 days (IQR 8–16) for high-
volume hospitals (p\ 0.0001). Before adjustment, no
significant differences were seen in the incidence of wound
complications (p = 0.69), esophageal perforation
(p = 0.39), or median hospital charges (p = 0.19).
After adjusting for patient and hospital characteristics,
patients at low-volume hospitals were significantly more
likely to have a complication [odds ratio (OR) 1.40, 95%
confidence interval (CI) 1.15–1.70; p = 0.0007], whereas
no significant difference in the overall incidence of com-
plications was seen in intermediate hospitals (OR 1.10,
95% CI 0.97–1.26; p = 0.14) [Table 2]. Specifically,
patients at low-volume hospitals were more likely to have
postoperative infection (OR 1.52, 95% CI 1.16–2.00),
bleeding (OR 1.36, 95% CI 1.08–1.72), renal failure (OR
1.74, 95% CI 1.23–2.47), respiratory failure (OR 1.58, 95%
CI 1.26–1.98), and inpatient mortality (OR 2.17, 95% CI
1.49–3.15). While overall complications were not different,
patients at intermediate-volume hospitals were more likely
to have postoperative infection (OR 1.25, 95% CI
1.03–1.52), renal failure (OR 1.34, 95% CI 1.04–1.73),
respiratory failure (OR 1.36, 95% CI 1.15–1.60), and
inpatient mortality (OR 1.62, 95% CI 1.20–2.17). On
average, patients at low-volume hospitals stayed 1.74 days
longer (95% CI 0.32–3.15) and patients at intermediate-
volume hospitals stayed 1.48 days longer (95% CI
0.51–2.45).
Between 2000 and 2011, the rate of procedures across
hospital volume significantly changed in the US. Specifi-
cally, the percentage of esophagectomies performed at
high-volume centers increased from 29.2 to 68.5%, while
the percentage at low- and intermediate-volume hospitals
decreased from 24.9 to 9.6% and 45.9 to 21.9%, respec-
tively (p\ 0.0001) [Fig. 1]. The trend towards high-
volume hospitals was different among the different country
regions: South (7.7–54.3%), West (15.0–67.6%), Midwest
(37.3–67.7%), and Northeast (55.8–86.8%) (p\ 0.0001)
[Fig. 2].
Overall, between 2000 and 2011, the inpatient mortality
rate after esophagectomy dropped from 10.0 to 3.5%
(p = 0.006). When stratified by household income, the
average reduction in yearly mortality was significantly
higher among low household income patients (30.0–2.3%)
than medium/high/highest household income patients
(9.1–3.6%) [p = 0.02]. While the rates of mortality were
different between non-Hispanic White patients and other
race patients in 2000 (8.5% vs. 21.1%; p\ 0.0001), the
average decrease in mortality over time was relatively
consistent between the two groups (p = 0.13). Similarly,
although the rates of mortality were significantly different
in 2000 between public and private primary insurance
patients (14.3% vs. 3.9%; p\ 0.0001), there were similar
decreases in mortality across the two groups (p = 0.10)
[Fig. 3].
DISCUSSION
The aims of this study were to determine if a process of
spontaneous centralization of esophageal cancer surgery
occurred in the US, and to establish its impact on postop-
erative mortality. We found that the percentage of
procedures performed at high-volume hospitals signifi-
cantly increased nationwide in the last decade, and the
postoperative mortality rate dropped from 10.0% in 2000 to
3.5% in 2011.
Several studies have shown the benefits of concentrating
esophageal cancer surgery in high-volume centers.8–11
Wouters et al.8 analyzed a cohort of patients who under-
went esophagectomy after a centralization project in The
Netherlands. They found that along with a reduction in
postoperative morbidity and length of stay, mortality fell
from 12 to 4%.8 Markar et al.9 performed a meta-analysis
and demonstrated an increase in 30-day mortality and
TABLE 1 Distribution of patient and hospital characteristics among adult patients undergoing esophagectomy between 2000 and 2014
(n = 5235)
Low volume [671 (12.8%)] Intermediate volume [1831 (35.0%)] High volume [2733 (52.2%)] p value
Sex
Male 539 (80.3) 1468 (80.2) 2240 (82.0) 0.27
Female 132 (19.7) 363 (19.8) 493 (18.0) –
Age, years [mean (SD)] 63.2 (10.2) 63.5 (10.0) 63.4 (10.3) 0.81
Race/ethnicity
Non-hispanic white 439 (83.0) 1269 (85.5) 1999 (90.1) \ 0.0001
Non-hispanic black 47 (8.9) 97 (6.5) 75 (3.4) \ 0.0001
Hispanic 23 (4.4) 57 (3.8) 81 (3.7) 0.75
Other 20 (3.8) 61 (4.1) 63 (2.8) 0.10
Missing 142 347 515 –
Primary insurance
Private 274 (41.1) 723 (39.6) 1315 (48.3) \ 0.0001
Public 363 (54.4) 1030 (56.4) 1319 (48.4) \ 0.0001
Other/self-pay 30 (4.5) 72 (4.0) 89 (3.3) 0.23
Household incomea
Low 117 (17.9) 341 (19.0) 492 (18.5) 0.83
Medium 181 (27.8) 448 (24.9) 629 (23.6) 0.08
High 186 (28.5) 506 (28.2) 715 (26.9) 0.53
Highest 168 (25.8) 502 (27.9) 826 (31.0) 0.009
Comorbidities
Hypertension 242 (36.1) 804 (43.9) 1217 (44.5) 0.0003
Diabetes 109 (16.2) 313 (17.1) 418 (15.3) 0.26
Obesity 37 (5.5) 118 (6.4) 155 (5.7) 0.50
Renal insufficiency 23 (3.4) 59 (3.2) 52 (1.9) 0.007
Coronary artery disease 84 (12.5) 228 (12.5) 386 (14.1) 0.21
Peripheral vascular disease 12 (1.8) 42 (2.3) 64 (2.3) 0.68
COPD 23 (3.4) 83 (4.5) 79 (2.9) 0.01
Sleep apnea 21 (3.1) 85 (4.6) 98 (3.6) 0.11
Hospital size
Small 69 (10.3) 134 (7.3) 206 (7.5) 0.03
Medium 191 (28.6) 360 (19.7) 303 (11.1) \ 0.0001
Large 407 (61.0) 1332 (73.0) 2224 (81.4) \ 0.0001
Hospital type
Urban, teaching 349 (52.3) 1363 (74.6) 2590 (94.8) \ 0.0001
Urban, non-teaching 277 (41.5) 395 (21.6) 77 (2.8) \ 0.0001
Rural, non-teaching 41 (6.2) 68 (3.7) 66 (2.4) \ 0.0001
Hospital region
Northeast 90 (13.4) 323 (17.6) 862 (31.5) \ 0.0001
Midwest 178 (26.5) 464 (25.3) 619 (22.7) 0.03
South 252 (37.6) 661 (36.1) 722 (26.4) \ 0.0001
West 151 (22.5) 383 (20.9) 530 (19.4) 0.15
Data are expressed as n (%) unless otherwise specified
Bold values indicate statistical significance (p\ 0.05)
SD standard deviation, COPD chronic obstructive pulmonary disease
aBetween 2000 and 2002, household income was characterized by the following quartiles: $1–$24,999 (low), $25,000–$34,999 (medium),
$35,000–$44,999 (high), and $45,000 and above (highest); from 2003 onward, income was characterized into quartiles within each ZIP code
inhospital mortality associated with esophagectomy per-
formed at low-volume hospitals. Similarly, a recent
European multicenter study showed that low-volume cen-
ters were associated with increased 30-day postoperatively
mortality.11 However, different thresholds have been used
to define low- and high-volume institutions. For instance,
The American Leapfrog group established a minimum
hospital case volume of 13 esophageal resections in
response to known improved outcomes in larger-volume
centers.13 We decided to adopt a cut-off of 20 operations
per year for high-volume hospitals, based on previous
studies, to achieve low postoperative mortality.14,15 We
further classified into low (\ 5 procedures) and interme-
diate (5–20 procedures) to differentiate centers with very
few cases per year. In our analysis, both patients at low-
(OR 2.17) and intermediate-volume centers (OR 1.62) had
significantly higher incidences of postoperative mortality
compared with high-volume centers. In addition, high-
volume hospitals were associated with less postoperative
morbidity and shorter length of hospital stay. Our data
suggest that the higher mortality in low- and intermediate-
volume hospitals was probably a consequence of the higher
morbidity seen at these centers, and a lower ability to
rescue. In addition, other factors across hospitals played a
role, since operative mortality rates are unlikely to be a
linear product of any single factor, such as volume.
Improvements in surgical technique and perioperative care,
dedicated anesthetic teams, and high dependency units
certainly contributed. In addition, the multidisciplinary
approach for esophageal cancer management at specialized
centers determines a better patient selection.
TABLE 2 Adjusted odds ratios of low and intermediate surgical-volume hospitals, compared with high-volume hospitals, on postoperative
complications, length of stay, and hospital charges among adult patients undergoing esophagectomy
Low volume Intermediate volume
ORa 95% CI p value ORa 95% CI p value
Postoperative complications
Venous thromboembolism 0.67 0.44–1.02 0.06 0.72 0.55–0.95 0.02
Wound complications 0.79 0.43–1.45 0.44 1.01 0.69–1.48 0.95
Infection 1.52 1.16–2.00 0.002 1.25 1.03–1.52 0.03
Esophageal perforation 1.70 0.54–5.32 0.36 1.82 0.84–3.94 0.13
Bleeding 1.36 1.08–.72 0.008 1.09 0.93–1.29 0.29
Cardiac failure 1.42 0.96–2.09 0.08 1.25 0.94–1.66 0.12
Renal failure 1.74 1.23–2.47 0.002 1.34 1.04–1.73 0.02
Respiratory failure 1.58 1.26–1.98 \0.0001 1.36 1.15–1.60 0.0002
Shock 2.03 0.83–5.00 0.12 1.85 0.93–3.67 0.08
Mortality 2.17 1.49–3.15 \0.0001 1.62 1.20–2.17 0.002
Any complicationb 1.40 1.15–1.70 0.0007 1.10 0.97–1.26 0.14
CIE 95% CI p value CIE 95% CI p value
Length of stay, days 1.74 0.32–3.15 0.02 1.48 0.51, 2.45 0.003
Charges, thousands - 5.04 - 23.23–13.16 0.59 - 7.96 - 20.40–4.48 0.21
Bold values indicate statistical significance (p\ 0.05)
OR odds ratio, CI confidence interval, CIE change in estimate
aAdjusted for admit year, age (modeled as a restricted cubic spline), sex, race/ethnicity, insurance type, income, comorbidities, hospital size,
location/teaching status, and region; missing data were imputed using Markov Chain Monte Carlo multiple imputation

































FIG. 1 Yearly rate of esophagectomies in the US, stratified by
hospital volume
Interestingly, despite numerous obstacles, the US has
experienced a spontaneous centralization of esophageal
cancer surgery towards high-volume centers in the last
decade. While in 2000 the percentage of esophagectomies
performed at high-volume centers was 29.2%, this number
rose to 68.5% in 2011. This trend demonstrates how
reporting volume–outcomes data drives patients and pro-
fessional practice. Without restrictions and without
designated centers of excellence, esophageal cancer
patients have flowed towards high-volume hospitals. This
shift might be due in part to the process of consolidation of
healthcare systems that has occurred in the last decade.
Small community hospitals have joined large academic
centers so that the more complex procedures are performed
in high-volume centers. In addition, the medical board of
these new healthcare systems might not grant privileges for
operations such as esophagectomies to surgeons who pre-
viously performed one or two of these procedures per year.
Finally, as the data on the relationship between volume and
outcome are today of public dominion, individual surgeons
might be more reluctant to perform operations linked to
high morbidity and mortality for the fear of litigation.16
As we intended to capture a broad snapshot of the cancer
care delivery system in the entire US, we also analyzed the
trend of centralization in the different regions of the
country. Remarkably, in 2000 only 7% of the esophagec-
tomies were performed at high-volume hospitals in the
South. While this percentage increased to 54.3% by 2011,
we believe this number should be higher. Compared with
the South, the Northeast had a baseline of 55.8% proce-
dures at high-volume centers in 2000, increasing to 86.8%
in 2011. These findings might be explained by the high
concentration of tertiary and quaternary hospitals in a rel-
atively small region, which allow patients to travel shorter
distances. We can also speculate that higher socioeconomic
status allowed more patients and their families to travel to
urban teaching hospitals. Overall, we believe geographical
and socioeconomic barriers for access to high-quality
cancer care should be explored.
Along with the centralization of esophageal cancer
surgery in the US, the overall mortality rate after
esophagectomy dropped from 10.0% in 2000 to 3.5% in
2011. As we were concerned that regionalization of cancer































































































































































































FIG. 2 Yearly rate of esophagectomies performed at high-volume centers, stratified by US regions
whether vulnerable populations would also benefit by this
process. Interestingly, the reduction in postoperative mor-
tality was higher among low household income patients,
and showed no significant differences between non-His-
panic White patients and other race patients, as well as
between private primary insurance patients and public
primary insurance patients. A further centralized network
could be challenging because patients would need to travel
longer distances to undergo surgery in a regional center of
excellence. A recent study reported that esophageal cancer
patients who travel longer distances to high-volume centers
have significantly different treatment and better outcomes
than patients who stay close to home at low-volume cen-
ters.17 Therefore, healthcare providers and payers should
be encouraged to address the economic impact of a cen-
tralized cancer care system in order to avoid disparities in
access to care at a population level. Overall, our findings
suggest that centralization of esophageal cancer care did
not result in impaired access to care.
Limitations of our study include that the NIS does not
link hospital records, meaning that patient outcomes,
including complications, re-admission, and mortality,
occurring after the initial hospital discharge were unable to
be measured. There is also potential for coding errors and
differences in coding practices across hospitals in a large
administrative database. In addition, the NIS dataset is
limited by the lack of cancer-specific information, such as
stage, cell type, or the utilization of neoadjuvant therapy.
Finally, we did not make any distinction between different
surgical approaches and reconstructive techniques.
Despite these limitations, our study shows the benefits of
concentrating esophageal cancer surgery in high-volume
centers, and the temporal trend of centralization of
esophagectomies for cancer across the US.
CONCLUSIONS
The US experienced a nationwide spontaneous central-



































































































































FIG. 3 Yearly rate of inpatient mortality after esophagectomy in the US for the overall population, stratified by race, household income level,
and insurance type
treatment of esophageal cancer. This process contributed to
reducing the mortality rate after esophagectomy without
causing health disparities.
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